-
Product Insights
Myocardial Fibrosis - Drugs In Development, 2024
Empower your strategies with our Myocardial Fibrosis – Drugs In Development, 2024 report and make more profitable business decisions. Myocardial fibrosis is an abnormal thickening of the heart valves due to inappropriate proliferation of cardiac fibroblasts. Symptoms include chest pain, some abdominal swelling, nausea, and fatigue. The Myocardial Fibrosis drugs in development market research report provide comprehensive information on the therapeutics under development for Myocardial Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of...
-
Product Insights
Heart Valve Disease - Drugs In Development, 2024
Empower your strategies with our Heart Valve Disease – Drugs In Development, 2024 report and make more profitable business decisions. Heart valve diseases are problems affecting one or more of the four valves in the heart, where the heart valve or valves do not open or close properly with every heartbeat, causing disruption of blood flow. Stenosis, regurgitation, and atresia are a few types of heart valve diseases. Signs and symptoms can range from mild to severe, including chest pain, irregular...
-
Product Insights
Tachycardia (Tachyarrhythmias) - Drugs In Development, 2024
Empower your strategies with our Tachycardia (Tachyarrhythmias) – Drugs In Development, 2024 report and make more profitable business decisions. Tachycardia also known as tachyarrhythmias is a condition where heartbeats >100 beats per minute, which is faster than normal heartbeat. Tachycardia is commonly observed during running, exercise, shock, or anxious cases but it is a concern when occurring at rest. There are 3 types of tachycardia which are sinus, ventricular and supraventricular. Sinus tachycardia commonly occurs after a strenuous exercise, in supraventricular...
-
Product Insights
Aortic Valve Diseases - Drugs In Development, 2024
Empower your strategies with our Aortic Valve Diseases – Drugs In Development, 2024 report and make more profitable business decisions. Aortic Valve Disease (AVD) is a type of valve disease where hearts aortic valve does not work properly. Aortic valve controls the flow of blood from heart to all the body parts. When there is a damage to the aortic valve blood flow is affected. The 2 main aortic valve diseases are aortic stenosis and aortic regurgitation. In aortic stenosis blood...
-
Product Insights
Pre-Eclampsia - Drugs In Development, 2024
Empower your strategies with our Pre-Eclampsia – Drugs In Development, 2024 report and make more profitable business decisions. Hypertension during pregnancy is termed pre-eclampsia. It generally occurs during the second trimester or after giving birth. Although there is no exact cause but stress, abnormal placentation is believed to lead to pre-eclampsia. Obesity, underlying diseased conditions hypertension, diabetes, kidney disease, or genetic causes may also lead to this. When pathologically examined high levels of protein in the urine (proteinuria), renal insufficiency, and...
-
Product Insights
Edema - Drugs In Development, 2024
Empower your strategies with our Edema – Drugs In Development, 2024 report and make more profitable business decisions. Edema is a condition where excess fluid accumulation is observed in the limbs bilaterally, appearing as as puffiness or swelling. This condition can be temporary, depending on the cause of the condition. There are various etiological factors: long-standing, low protein levels, pregnancy, chronic kidney disease (CKD), congestive heart failure (CHF), liver cirrhosis, venous insufficiency, and lung conditions like emphysema. Physical examination is the...
-
Product Insights
Myocarditis - Drugs In Development, 2024
Empower your strategies with our Myocarditis – Drugs In Development, 2024 report and make more profitable business decisions. Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial, or fungal infections that reach the heart. Symptoms include chest pain; rapid or abnormal heartbeat; shortness of breath, at rest or during physical activity; fluid retention with swelling of the legs, ankles, and feet; and fatigue. Treatment includes antibiotics, anti-inflammatory medicines to reduce swelling;...
-
Product Insights
Thrombotic Microangiopathy - Drugs In Development, 2024
Empower your strategies with our Thrombotic Microangiopathy – Drugs In Development, 2024 report and make more profitable business decisions. Thrombotic Microangiopathy is a life-threatening group of hematological diseases characterized by hemolytic anemia (destruction of red blood cells), thrombocytopenia, and microthrombi leading to ischemic tissue injury. In severe cases, TMA leads to kidney injury. Mutations in the ADAMTS13 gene and atypical hemolytic uremic syndrome cause TMA. It can also be caused by infectious diseases, blood-borne diseases, drug-induced etc. Complete blood count to...
-
Product Insights
Ventricular Tachycardia - Drugs In Development, 2024
Empower your strategies with our Ventricular Tachycardia – Drugs In Development, 2024 report and make more profitable business decisions. Ventricular tachycardia is a very fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia include dizziness, fainting, fatigue, chest pain, and shortness of breath. Causes include cardiomyopathy, ischemic heart disease, and heart failure. Risk factors include age, family history, and medical history. Treatment includes antiarrhythmic medication. The Ventricular Tachycardia drugs in development market research report provide comprehensive information on...
-
Product Insights
Aortic Valve Stenosis - Drugs In Development, 2024
Empower your strategies with our Aortic Valve Stenosis – Drugs In Development, 2024 report and make more profitable business decisions. Aortic valve stenosis (AVS) is caused by narrowing of the heart's aortic valve opening. The valve between the lower left heart chamber and the body's main artery (aorta) is narrowed and doesn't open fully, which obstructs blood flow from the heart into the aorta and onward to the rest of the body. AVS can range from mild to severe. Signs and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.